Global Over the Counter (OTC) Drugs & Dietary Supplements Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Over the Counter (OTC) Drugs & Dietary Supplements market report explains the definition, types, applications, major countries, and major players of the Over the Counter (OTC) Drugs & Dietary Supplements market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Alkalon A/S

    • Sanofi SA

    • Allergan, Plc

    • Alcon Inc

    • Johnson & Johnson

    • Merck & Co Inc

    • AstraZeneca plc

    • Bayer Healthcare AG

    • Pfizer Inc

    • Roche Holding AG

    • The Colgate-Palmolive Company

    • Alacer Corp

    • Alliance Healthcare

    • Novartis International AG

    • Bausch & Lomb

    • AbbVie Inc

    • Gilead Sciences

    • GlaxoSmithKline plc

    • Alfresa Pharma Corporation

    • Reckitt Benckiser Plc

    By Type:

    • Vitamin and Dietary Supplements

    • Cough & Cold Products

    • Analgesics

    • Gastrointestinal Products

    • Sleep Aids

    • Otic Products

    • Wart Removers

    • Mouth Care Products

    • Ophthalmic Products

    • Other

    By End-User:

    • Pharmacies

    • Grocery Stores

    • Vitamin

    • Health Food Stores

    • Online Pharmacies

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Over the Counter (OTC) Drugs & Dietary Supplements Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Over the Counter (OTC) Drugs & Dietary Supplements Outlook to 2028- Original Forecasts

    • 2.2 Over the Counter (OTC) Drugs & Dietary Supplements Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Over the Counter (OTC) Drugs & Dietary Supplements Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Over the Counter (OTC) Drugs & Dietary Supplements Market- Recent Developments

    • 6.1 Over the Counter (OTC) Drugs & Dietary Supplements Market News and Developments

    • 6.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Deals Landscape

    7 Over the Counter (OTC) Drugs & Dietary Supplements Raw Materials and Cost Structure Analysis

    • 7.1 Over the Counter (OTC) Drugs & Dietary Supplements Key Raw Materials

    • 7.2 Over the Counter (OTC) Drugs & Dietary Supplements Price Trend of Key Raw Materials

    • 7.3 Over the Counter (OTC) Drugs & Dietary Supplements Key Suppliers of Raw Materials

    • 7.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Rate of Raw Materials

    • 7.5 Over the Counter (OTC) Drugs & Dietary Supplements Cost Structure Analysis

      • 7.5.1 Over the Counter (OTC) Drugs & Dietary Supplements Raw Materials Analysis

      • 7.5.2 Over the Counter (OTC) Drugs & Dietary Supplements Labor Cost Analysis

      • 7.5.3 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Expenses Analysis

    8 Global Over the Counter (OTC) Drugs & Dietary Supplements Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Export by Region (Top 10 Countries) (2017-2028)

    9 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook by Types and Applications to 2022

    • 9.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Vitamin and Dietary Supplements Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Cough & Cold Products Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Analgesics Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Sleep Aids Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Otic Products Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Wart Removers Consumption and Growth Rate (2017-2022)

      • 9.1.8 Global Mouth Care Products Consumption and Growth Rate (2017-2022)

      • 9.1.9 Global Ophthalmic Products Consumption and Growth Rate (2017-2022)

      • 9.1.10 Global Other Consumption and Growth Rate (2017-2022)

    • 9.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Pharmacies Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Grocery Stores Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Vitamin Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Health Food Stores Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Outlook till 2022

    • 10.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.2.2 Canada Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.2.3 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.2 UK Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.3 Spain Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.4 Belgium Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.5 France Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.6 Italy Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.7 Denmark Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.8 Finland Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.9 Norway Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.10 Sweden Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.11 Poland Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.12 Russia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.3.13 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.3 India Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.4 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.5 Pakistan Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.6 Bangladesh Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.7 Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.8 Thailand Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.9 Singapore Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.10 Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.11 Philippines Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.4.12 Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.2 Colombia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.3 Chile Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.4 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.5 Venezuela Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.6 Peru Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.7 Puerto Rico Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.5.8 Ecuador Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.6.2 Kuwait Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.6.3 Oman Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.6.4 Qatar Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.7.2 South Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.7.3 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.7.4 Algeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

      • 10.8.2 New Zealand Over the Counter (OTC) Drugs & Dietary Supplements Consumption (2017-2022)

    11 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitive Analysis

    • 11.1 Alkalon A/S

      • 11.1.1 Alkalon A/S Company Details

      • 11.1.2 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.1.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sanofi SA

      • 11.2.1 Sanofi SA Company Details

      • 11.2.2 Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.2.4 Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Allergan, Plc

      • 11.3.1 Allergan, Plc Company Details

      • 11.3.2 Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.3.4 Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Alcon Inc

      • 11.4.1 Alcon Inc Company Details

      • 11.4.2 Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.4.4 Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Johnson & Johnson

      • 11.5.1 Johnson & Johnson Company Details

      • 11.5.2 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.5.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Merck & Co Inc

      • 11.6.1 Merck & Co Inc Company Details

      • 11.6.2 Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.6.4 Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 AstraZeneca plc

      • 11.7.1 AstraZeneca plc Company Details

      • 11.7.2 AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.7.4 AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Bayer Healthcare AG

      • 11.8.1 Bayer Healthcare AG Company Details

      • 11.8.2 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.8.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Pfizer Inc

      • 11.9.1 Pfizer Inc Company Details

      • 11.9.2 Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.9.4 Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Roche Holding AG

      • 11.10.1 Roche Holding AG Company Details

      • 11.10.2 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.10.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 The Colgate-Palmolive Company

      • 11.11.1 The Colgate-Palmolive Company Company Details

      • 11.11.2 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.11.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Alacer Corp

      • 11.12.1 Alacer Corp Company Details

      • 11.12.2 Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.12.4 Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Alliance Healthcare

      • 11.13.1 Alliance Healthcare Company Details

      • 11.13.2 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.13.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    • 11.14 Novartis International AG

      • 11.14.1 Novartis International AG Company Details

      • 11.14.2 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.14.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.14.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.14.5 Recent Research and Development Strategies

    • 11.15 Bausch & Lomb

      • 11.15.1 Bausch & Lomb Company Details

      • 11.15.2 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.15.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.15.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.15.5 Recent Research and Development Strategies

    • 11.16 AbbVie Inc

      • 11.16.1 AbbVie Inc Company Details

      • 11.16.2 AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.16.3 AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.16.4 AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.16.5 Recent Research and Development Strategies

    • 11.17 Gilead Sciences

      • 11.17.1 Gilead Sciences Company Details

      • 11.17.2 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.17.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.17.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.17.5 Recent Research and Development Strategies

    • 11.18 GlaxoSmithKline plc

      • 11.18.1 GlaxoSmithKline plc Company Details

      • 11.18.2 GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.18.3 GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.18.4 GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.18.5 Recent Research and Development Strategies

    • 11.19 Alfresa Pharma Corporation

      • 11.19.1 Alfresa Pharma Corporation Company Details

      • 11.19.2 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.19.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.19.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.19.5 Recent Research and Development Strategies

    • 11.20 Reckitt Benckiser Plc

      • 11.20.1 Reckitt Benckiser Plc Company Details

      • 11.20.2 Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

      • 11.20.3 Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

      • 11.20.4 Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

      • 11.20.5 Recent Research and Development Strategies

    12 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Outlook by Types and Applications to 2028

    • 12.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Vitamin and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Cough & Cold Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global Otic Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Wart Removers Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.8 Global Mouth Care Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.9 Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.10 Global Other Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.4 Global Health Food Stores Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.5 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Over the Counter (OTC) Drugs & Dietary Supplements Market Analysis and Outlook to 2028

    • 13.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.2.2 Canada Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.2 UK Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.3 Spain Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.5 France Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.6 Italy Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.8 Finland Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.9 Norway Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.11 Poland Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.12 Russia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.3 India Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.3 Chile Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.6 Peru Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.3 Oman Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Over the Counter (OTC) Drugs & Dietary Supplements

    • Figure of Over the Counter (OTC) Drugs & Dietary Supplements Picture

    • Table Global Over the Counter (OTC) Drugs & Dietary Supplements Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Over the Counter (OTC) Drugs & Dietary Supplements Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Vitamin and Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Global Cough & Cold Products Consumption and Growth Rate (2017-2022)

    • Figure Global Analgesics Consumption and Growth Rate (2017-2022)

    • Figure Global Gastrointestinal Products Consumption and Growth Rate (2017-2022)

    • Figure Global Sleep Aids Consumption and Growth Rate (2017-2022)

    • Figure Global Otic Products Consumption and Growth Rate (2017-2022)

    • Figure Global Wart Removers Consumption and Growth Rate (2017-2022)

    • Figure Global Mouth Care Products Consumption and Growth Rate (2017-2022)

    • Figure Global Ophthalmic Products Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Grocery Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Vitamin Consumption and Growth Rate (2017-2022)

    • Figure Global Health Food Stores Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)

    • Figure Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Table North America Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure United States Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Canada Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Mexico Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure Germany Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure UK Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Spain Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Belgium Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure France Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Italy Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Denmark Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Finland Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Norway Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Sweden Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Poland Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Russia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Turkey Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table APAC Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure China Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Japan Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure India Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure South Korea Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Thailand Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Singapore Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Philippines Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table South America Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure Brazil Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Colombia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Chile Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Argentina Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Peru Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table GCC Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure Bahrain Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Oman Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Qatar Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure South Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Egypt Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure Algeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Oceania Over the Counter (OTC) Drugs & Dietary Supplements Consumption by Country (2017-2022)

    • Figure Australia Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Over the Counter (OTC) Drugs & Dietary Supplements Consumption and Growth Rate (2017-2022)

    • Table Alkalon A/S Company Details

    • Table Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Sanofi SA Company Details

    • Table Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Sanofi SA Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Allergan, Plc Company Details

    • Table Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Allergan, Plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Alcon Inc Company Details

    • Table Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Alcon Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Johnson & Johnson Company Details

    • Table Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Merck & Co Inc Company Details

    • Table Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Merck & Co Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table AstraZeneca plc Company Details

    • Table AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table AstraZeneca plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Bayer Healthcare AG Company Details

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Pfizer Inc Company Details

    • Table Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Pfizer Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Roche Holding AG Company Details

    • Table Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table The Colgate-Palmolive Company Company Details

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Alacer Corp Company Details

    • Table Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Alacer Corp Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Alliance Healthcare Company Details

    • Table Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Novartis International AG Company Details

    • Table Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Bausch & Lomb Company Details

    • Table Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table AbbVie Inc Company Details

    • Table AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table AbbVie Inc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Gilead Sciences Company Details

    • Table Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table GlaxoSmithKline plc Company Details

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table GlaxoSmithKline plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Alfresa Pharma Corporation Company Details

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Table Reckitt Benckiser Plc Company Details

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Sales, Price, Value and Gross Profit (2017-2022)

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Main Business and Markets Served

    • Table Reckitt Benckiser Plc Over the Counter (OTC) Drugs & Dietary Supplements Product Portfolio

    • Figure Global Vitamin and Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cough & Cold Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Gastrointestinal Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Sleep Aids Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Otic Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Wart Removers Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mouth Care Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Ophthalmic Products Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Grocery Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vitamin Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Health Food Stores Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Table North America Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure United States Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Germany Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure China Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Brazil Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast by Country (2022-2028)

    • Figure Australia Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Over the Counter (OTC) Drugs & Dietary Supplements Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.